This article is more than 5 years old. Information may no longer be current.
Brain stimulation device for patients with impaired vision available outside US
Click Here to Manage Email Alerts
EBS Technologies announced Monday that the University Medical Center Hamburg-Eppendorf is now offering the use of Next Wave technology.
Next Wave is a brain stimulation device designed to expand the visual field of patients with impaired vision caused by optic nerve damage or brain injuries such as trauma, degeneration or tumor resection, according to the release.
“It is well known that there is a tremendous unmet clinical need for the treatment of vision impairment caused by a variety of different neurological disorders, such as neuropathy of the optic nerve,” Ulf Pommerening, chief executive officer of EBS, said in the press release. “Three out of five persons who are disabled from impaired vision as a result of optic nerve neuropathy, brain injury or stroke are potentially treatable with our Next Wave therapy.”
EBS released a study in June 2013 in which patients showed a 24% average increase of their total visual field after being treated with Next Wave technology compared to patients who did not receive the treatment.
Next Wave has not been approved for sale or investigational use in the U.S., according to the release.